Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 1
2016 1
2019 1
2020 6
2021 13
2022 9
2023 19
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Tiwari A, Tashiro K, Dixit A, Soni A, Vogel K, Hall B, Shafqat I, Slaughter J, Param N, Le A, Saunders E, Paithane U, Garcia G, Campos AR, Zettervall J, Carlson M, Starr TK, Marahrens Y, Deshpande AJ, Commisso C, Provenzano PP, Bagchi A. Tiwari A, et al. Among authors: tashiro k. Gastroenterology. 2020 Nov;159(5):1882-1897.e5. doi: 10.1053/j.gastro.2020.07.046. Epub 2020 Aug 5. Gastroenterology. 2020. PMID: 32768595 Free PMC article.
Prognostic value of PSA bounce after definitive radiotherapy revisited.
Urabe F, Kimura T, Sasaki H, Tashiro K, Iwatani K, Aoki M, Sato S, Takahashi H, Miki K, Egawa S. Urabe F, et al. Among authors: tashiro k. Int J Clin Oncol. 2022 Feb;27(2):411-417. doi: 10.1007/s10147-021-02053-0. Epub 2021 Oct 22. Int J Clin Oncol. 2022. PMID: 34677737
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
Shiota M, Takamatsu D, Matsui Y, Yokomizo A, Morizane S, Saito R, Miyake M, Tsutsumi M, Yamamoto Y, Tashiro K, Tomida R, Narita S, Edamura K, Yamaguchi T, Hashimoto K, Kato M, Kasahara T, Yoshino T, Akamatsu S, Kaneko T, Matsukawa A, Matsumoto R, Joraku A, Saito T, Kato T, Kato M, Enokida H, Sakamoto S, Terada N, Kanno H, Nishiyama N, Kimura T, Kitamura H, Eto M; Japanese Urological Oncology Group. Shiota M, et al. Among authors: tashiro k. Ann Surg Oncol. 2024 Jun;31(6):3872-3879. doi: 10.1245/s10434-024-14999-2. Epub 2024 Feb 14. Ann Surg Oncol. 2024. PMID: 38353798
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
Kagawa H, Urabe F, Kiuchi Y, Katsumi K, Yamaguchi R, Suhara Y, Yoshihara K, Goto Y, Sadakane I, Yata Y, Saito S, Kurawaki S, Ajisaka S, Miyajima K, Takahashi K, Iwatani K, Imai Y, Sakanaka K, Nakazono M, Kurauchi T, Kayano S, Onuma H, Aikawa K, Yanagisawa T, Tashiro K, Tsuzuki S, Furuta A, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Kagawa H, et al. Among authors: tashiro k. Int J Clin Oncol. 2024 Jan;29(1):55-63. doi: 10.1007/s10147-023-02424-9. Epub 2023 Oct 21. Int J Clin Oncol. 2024. PMID: 37863996
Knotted ureteral single-J stent in a patient with ureterocutaneostomy.
Koike Y, Urabe F, Iwatani K, Nukariya Y, Tanaka M, Tashiro K, Kimura T, Tsuzuki S, Egawa S. Koike Y, et al. Among authors: tashiro k. IJU Case Rep. 2021 Aug 5;4(6):382-385. doi: 10.1002/iju5.12355. eCollection 2021 Nov. IJU Case Rep. 2021. PMID: 34755062 Free PMC article.
Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events.
Katsuta M, Kimura T, Tashiro K, Murakami M, Hata K, Yanagisawa T, Onuma H, Yamamoto T, Sugaya S, Watanabe Y, Nobeyama Y, Egawa S, Asahina A. Katsuta M, et al. Among authors: tashiro k. Anticancer Res. 2022 Apr;42(4):2023-2028. doi: 10.21873/anticanres.15682. Anticancer Res. 2022. PMID: 35347024
52 results